Skip to main content
MNPR logo

MNPR · Monopar Therapeutics

$105.90 -5.22 (-4.70%) At close · Jul 20
Market Cap
$709.43M
Shares
6.70M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Chandler D. Robinson $10,637,821
Andrew J. Cittadine $4,706,431
Quan Vu $2,101,314
Fiscal 2024
Executive Total
Chandler D. Robinson $1,144,480
Andrew J. Cittadine $554,796
Karthik Radhakrishnan $320,160
Quan Vu
Fiscal 2023
Executive Total
Chandler D. Robinson $1,778,667
Andrew J. Cittadine $911,161
Kim R. Tsuchimoto $848,441
Karthik Radhakrishnan
Fiscal 2022
Executive Total
Chandler D. Robinson $1,601,448
Andrew J. Cittadine $752,326
Kim R. Tsuchimoto $695,128
Fiscal 2020
Executive Total
Chandler D. Robinson $1,588,564
Andrew P. Mazar $872,571
Kim R. Tsuchimoto $523,349
Fiscal 2019
Executive Total
Chandler D. Robinson $541,250
Andrew P. Mazar $465,500
Kim R. Tsuchimoto $183,225
Key facts CIK 1645469 CUSIP 61023L207 13F (30d) 4 filings 4 filers Visit website Investor relations